Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

ACA has helped healthcare stocks boom

The Affordable Care Act has helped launch healthcare stocks into the stratosphere over the last eight years, contrary to what some critics of the healthcare law believed would happen.

New Medicare Advantage plan launches with $300M in funding

Devoted Health, a new Medicare Advantage plan, has officially launched after securing $300 million in a Series B funding round, the company announced.

Thumbnail

MITA praises new research calling for repeal of medical device tax

The Medical Imaging & Technology Alliance (MITA) has issued a statement in support of new research from the Pacific Research Institute (PRI) focused on issues with the medical device tax and why the PRI believes that tax should be repealed.

Thumbnail

Healthcare M&A slows 38% in third quarter

Mergers and acquisition activity among hospitals and health systems is showing signs of a slowdown, according to the latest findings from financial consulting firm Kaufman, Hall & Associates.

Thumbnail

Bloomberg: Athenahealth has five potential bidders

Athenahealth, a network-enabled services company for hospitals and ambulatory clients, has bids from at least five entities, according to a report from Bloomberg.

Thumbnail

FDA, DHS expand ongoing efforts to tackle medical device cybersecurity

The agreement—announced in an FDA press release published Oct. 16—is meant to increase information sharing about medical device cybersecurity vulnerabilities and threats, enhance shared technical capabilities and coordinate appropriate device testing.

Thumbnail

Walmart considering selling marijuana as medicine in Canada

As Canada is set to legalize marijuana use on Oct. 17, Walmart—the world’s largest employer—is seriously considering adding cannabis products alongside other medications in its aisles in the country, according to Hemp Industry Daily.

Thumbnail

Drug pricing transparency rule has no teeth

HHS proposed a new rule to require drug manufacturers to publish prices of medicines in television ads. However, the rule has no enforcement mechanism by the agency and relies on self-policing.